Bigul

Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of Rights Issue Committee Of Board Of Directors Dated 2Nd August 2023

We hereby inform that, in accordance with (i) the Letter of Offer dated July 07, 2023, and (ii) the Basis of Allotment finalised in consultation with the Registrar to the Issue and BSE Limited, (the Designated Stock Exchange for the Rights issue), the Rights Issue Committee of the Board of Directors of the Company has, at in its meeting held today, i.e., August 02, 2023, approved the allotment of 55,44,156 partly paid-up Equity Shares of face value of Rs. 10/- each on a rights basis, at an issue price of Rs.45 per Equity Share (including premium of Rs.35 per Equity Share) to the eligible applicants. The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs.10.50) paid on Application. Balance to be paid in not more than two calls as determined by our Board at its sole discretion from time to time.
02-08-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Umesh Ravindranath More
31-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Umesh Ravindranath More
24-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aritro Ashish Roy
22-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saima Jaid Kojar
21-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Umesh Ravindranath More
21-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Laxmikant Kabra
21-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna
21-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Vishwanath Hiremath
19-07-2023
Bigul

Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Vishwanath Hiremath
19-07-2023
Next Page
Close

Let's Open Free Demat Account